These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21931877)

  • 21. Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.
    Hendrickx S; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
    Parasitol Res; 2015 Jul; 114(7):2561-5. PubMed ID: 25877390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.
    Mondelaers A; Sanchez-Cañete MP; Hendrickx S; Eberhardt E; Garcia-Hernandez R; Lachaud L; Cotton J; Sanders M; Cuypers B; Imamura H; Dujardin JC; Delputte P; Cos P; Caljon G; Gamarro F; Castanys S; Maes L
    PLoS One; 2016; 11(4):e0154101. PubMed ID: 27123924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection.
    Honoré S; Garin YJ; Sulahian A; Gangneux JP; Derouin F
    FEMS Immunol Med Microbiol; 1998 Jul; 21(3):231-9. PubMed ID: 9718213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.
    Silva SC; Silva DF; Almeida TC; Perasoli FB; da Silva ATP; da Silva GN; Rezende SA
    Parasitol Res; 2018 Sep; 117(9):2881-2893. PubMed ID: 29943317
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Hendrickx S; Feijens PB; Escudié F; Chatelain E; Maes L; Caljon G
    ACS Infect Dis; 2024 Jun; 10(6):2101-2107. PubMed ID: 38733389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
    Eberhardt E; Mondelaers A; Hendrickx S; Van den Kerkhof M; Maes L; Caljon G
    Parasitol Res; 2016 Oct; 115(10):4061-70. PubMed ID: 27412759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
    Hendrickx S; Beyers J; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
    J Antimicrob Chemother; 2016 Jul; 71(7):1914-21. PubMed ID: 27084919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
    Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives.
    Tavares J; Ouaissi A; Silva AM; Lin PK; Roy N; Cordeiro-da-Silva A
    Parasitol Int; 2012 Jun; 61(2):360-3. PubMed ID: 22155672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.
    Fortin A; Hendrickx S; Yardley V; Cos P; Jansen H; Maes L
    J Antimicrob Chemother; 2012 Nov; 67(11):2707-12. PubMed ID: 22782488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.
    Agallou M; Athanasiou E; Kammona O; Tastsoglou S; Hatzigeorgiou AG; Kiparissides C; Karagouni E
    Front Immunol; 2019; 10():2749. PubMed ID: 31849951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection.
    Silvestre R; Cordeiro-Da-Silva A; Santarém N; Vergnes B; Sereno D; Ouaissi A
    J Immunol; 2007 Sep; 179(5):3161-70. PubMed ID: 17709531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
    Costa S; Machado M; Cavadas C; do Céu Sousa M
    Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis.
    Calvo-Álvarez E; Stamatakis K; Punzón C; Álvarez-Velilla R; Tejería A; Escudero-Martínez JM; Pérez-Pertejo Y; Fresno M; Balaña-Fouce R; Reguera RM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003666. PubMed ID: 25826250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes.
    Pinto EG; da Costa-Silva TA; Tempone AG
    Acta Trop; 2014 Sep; 137():206-10. PubMed ID: 24905294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Gontijo VS; Colombo FA; Ferreira Espuri P; Freitas PG; Nunes JB; Alves LB; Veloso MP; Alves RB; Freitas RP; Marques MJ
    Exp Parasitol; 2021; 226-227():108123. PubMed ID: 34144040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.